| Date | Target |
Transaction Type Value: $mlns |
Acquirer | Seller | ||
|---|---|---|---|---|---|---|
| 2011-11-01 |
10X Genomics
Life Science Pleasanton, California www.10Xgenomics.com 10X Genomics provides a genomics platform that upgrades the capabilities of existing short read sequencers. The Company does this through a combination of elegant microfluidics, chemistry, and bioinformatics. With the GemCode Platform, researchers can now find structural variants, haplotypes, and other valuable long range information while leveraging existing sequencing workflows. 10X Genomics was founded in 2012 and is based in Pleasanton, California. |
Venture |
Paladin Capital Group
|
- | ||
| 2011-10-03 |
Putney, Inc.
Life Science Portland, Maine www.putneyvet.com Putney, Inc. is a pharmaceutical company, providing high quality, cost-effective generic medicines for pets. Putney's reliable supply of affordable drug options empowers veterinarians, allowing them to provide the best possible medicine at the best possible price, and supports pet owners, helping them afford to comply with veterinary recommendations. |
Venture |
NewSpring Capital
|
- | ||
| 2011-09-27 |
Caidya
Life Science Morrisville, North Carolina www.caidya.com Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance. Caidya is a proprietary clinical technology to ensure trial transparency and data-driven decision-making. Caidya was founded in 2003 and is based in Morrisville, North Carolina. |
Venture |
Morgan Stanley Expansion Capital
Petra Capital Partners
Virgo Investment Group
|
- | ||
| 2011-09-20 |
NuScriptRX
Life Science Nashville, Tennessee www.nuscriptrx.com NuScriptRX is a pharmacy that serves the pharmaceutical needs of long-term care facilities and their residents. NuScriptRX is based in Nashville, Tennessee. |
Venture |
Envest Private Equity
Council Capital
|
- | ||
| 2011-09-13 |
AM-Pharma
Life Science Utrecht, Netherlands www.am-pharma.com AM-Pharma is a biopharmaceutical company developing therapies based on recombinant human alkaline phosphatase. Its therapy, ilofotase alfa, targets acute kidney injury and rare diseases such as hypophosphatasia. AM-Pharma was founded in 2000 and is based in Utrecht, Netherlands. |
Venture |
Gilde Healthcare
Andera Partners
Idinvest Partners
EQT Life Sciences
Pfizer
|
- | ||
| 2011-08-10 |
T2 Biosystems, Inc.
Life Science Lexington, Massachusetts www.t2biosystems.com Rapid, decentralized molecular diagnostic tests and systems that detect fungal and bacterial infections, as well as complementary immunodiagnostics. |
Venture |
Aisling Capital
|
- | ||
| 2011-06-01 |
Esperance Pharmaceuticals
Life Science Baton Rouge, Louisiana www.esperancepharma.com Esperance Pharmaceuticals is a pre-clinical stage company developing lytic peptides conjugated to both antibody drug conjugates (ADCs) and Chimeric antigen receptor (CAR) T-cell therapy to make them more effective. Esperance Pharmaceuticals was founded in 2005 and is based in Baton Rouge, Louisiana. |
Venture |
Advantage Capital Partners
|
- | ||
| 2011-05-19 |
Advicenne
Life Science Paris, France www.advicenne.com Advicenne is a pharmaceutical company that specializes in pediatrics. Advicenne was founded in 2007 and is based in Paris, France. |
Venture |
Ixo Private Equity
|
- | ||
| 2011-05-17 |
Resolve Therapeutics LLC
Life Science Kirkland, Washington www.resolvebio.com Resolve Therapeutics is a private biotechnology company that is dedicated to the goal of improving the lives of patients suffering from lupus. |
Venture |
Easton Capital Investment Group
|
- | ||
| 2011-05-11 |
CardioDx, Inc.
Life Science Redwood City, California www.cardiodx.com CardioDx, Inc. is a molecular diagnostics company that serves cardiologists and their patients by offering clinically validated genomic tests to enhance patient care. The company is focused on the personalized management of patients with congestive heart failure, rhythm disturbances and atherosclerosis. |
Venture |
TPG
|
- | ||
| 2011-05-11 |
Naurex, Inc.
Life Science Evanston, Illinois www.naurex.com Naurex, Inc. is a clinical-stage biopharmaceutical company developing transformative therapies for challenging disorders of the central nervous system. |
Venture |
Adams Street Partners
|
- | ||
| 2011-04-27 |
Multiplicom N.V.
Life Science Niel, Belgium www.multiplicom.com Multiplicom N.V. is a developer, manufacturer and commercializes molecular diagnostic solutions, provided as kits, which enable personalized medicine. |
Venture |
GIMV
|
- | ||
| 2011-03-31 |
Acacia Pharma
Life Science Cambridge, United Kingdom www.acaciapharma.com Acacia Pharma is a pharmaceutical company specializing in the development of drugs for cancer supportive care. The growth in the cancer supportive care market has been driven by the increasing incidence of cancer, the expansion of effective cancer therapies and the desire to improve both the effectiveness of treatment and the quality of life of cancer patients. Acacia Pharma was founded in 2007 and is based in Cambridge, United Kingdom. |
Venture |
Gilde Healthcare
Eight Roads
|
- | ||
| Deal Article Deal Link | ||||||
| 2011-03-24 |
Genkyotex SA
Life Science Geneva, Switzerland www.genkyotex.com Genkyotex SA is a specialty pharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs. Genkyotex was founded in 2006 and is based in Geneva, Switzerland. |
Venture |
Edmond de Rothschild Private Equity
|
- | ||
| 2011-03-08 |
Ajinomoto Cambrooke, Inc.
Life Science Ayer, Massachusetts www.cambrooke.com Ajinomoto Cambrooke, Inc. is a therapeutic nutrition company and global provider of medical nutrition products for patients with serious, chronic, unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are today focused on inborn errors of metabolism and intractable epilepsy. |
Venture |
Galen Partners
|
- | ||
| 2011-02-25 |
Exagen
Life Science Vista, California www.exagen.com Exagen is a patient-focused, discovery-driven, CLIA-certified, CAP-accredited laboratory focused on providing physicians with products that address the significant unmet need for accurate and timely diagnosis, prognosis and monitoring of ARD/CTD. Exagen was founded in 2002 and is based in Vista, California. |
Venture |
Sun Mountain Capital
|
- | ||
| Avg |
$0.0
0.0x EBITDA 0.0x REVENUE |
|||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.
Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.
The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.
